The C-reactive protein-albumin-lymphocyte (CALLY) index, integrating markers of inflammation, nutritional status, and immune competence, has demonstrated prognostic relevance in solid tumors; however, its relevance in hematologic malignancies remains unexplored. The gene discussed is ALB; the disease is hematologic disorder.